Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 5 | 2015 | 261 | 1.210 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2017 | 116 | 1.100 |
Why?
|
| Bronchoscopy | 9 | 2017 | 54 | 0.880 |
Why?
|
| Pneumonia | 2 | 2015 | 62 | 0.560 |
Why?
|
| Hispanic Americans | 7 | 2016 | 772 | 0.480 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2017 | 116 | 0.470 |
Why?
|
| Self Care | 1 | 2015 | 97 | 0.440 |
Why?
|
| Transients and Migrants | 6 | 2016 | 197 | 0.420 |
Why?
|
| Male | 27 | 2019 | 19441 | 0.390 |
Why?
|
| Bronchodilator Agents | 2 | 2017 | 34 | 0.390 |
Why?
|
| Bronchial Neoplasms | 1 | 2013 | 5 | 0.390 |
Why?
|
| Cryotherapy | 1 | 2013 | 12 | 0.380 |
Why?
|
| Female | 25 | 2019 | 19945 | 0.370 |
Why?
|
| Scopolamine Derivatives | 1 | 2012 | 5 | 0.360 |
Why?
|
| Physicians | 1 | 2014 | 163 | 0.360 |
Why?
|
| Androstadienes | 1 | 2012 | 15 | 0.360 |
Why?
|
| Albuterol | 1 | 2012 | 17 | 0.360 |
Why?
|
| Middle Aged | 18 | 2017 | 11851 | 0.360 |
Why?
|
| Adult | 18 | 2016 | 9259 | 0.350 |
Why?
|
| Intensive Care Units | 2 | 2016 | 121 | 0.340 |
Why?
|
| Lung Neoplasms | 5 | 2017 | 423 | 0.330 |
Why?
|
| Humans | 32 | 2019 | 32282 | 0.320 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 77 | 0.320 |
Why?
|
| Blood Pressure Determination | 1 | 2010 | 106 | 0.320 |
Why?
|
| Aged | 14 | 2017 | 10263 | 0.300 |
Why?
|
| Prevalence | 8 | 2015 | 955 | 0.280 |
Why?
|
| Oxygen | 1 | 2009 | 138 | 0.280 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2019 | 56 | 0.280 |
Why?
|
| Exercise Test | 1 | 2009 | 217 | 0.270 |
Why?
|
| Walking | 1 | 2009 | 200 | 0.270 |
Why?
|
| Respiratory Tract Diseases | 3 | 2014 | 34 | 0.270 |
Why?
|
| Pulmonary Medicine | 4 | 2015 | 15 | 0.270 |
Why?
|
| Young Adult | 10 | 2016 | 2649 | 0.260 |
Why?
|
| Agriculture | 5 | 2014 | 94 | 0.240 |
Why?
|
| Pesticides | 2 | 2016 | 135 | 0.230 |
Why?
|
| Aged, 80 and over | 6 | 2016 | 3900 | 0.230 |
Why?
|
| Occupational Exposure | 2 | 2016 | 159 | 0.230 |
Why?
|
| Endosonography | 2 | 2015 | 55 | 0.220 |
Why?
|
| Age Factors | 5 | 2014 | 1179 | 0.210 |
Why?
|
| Postural Balance | 1 | 2016 | 142 | 0.210 |
Why?
|
| Adolescent | 8 | 2015 | 3519 | 0.210 |
Why?
|
| North Carolina | 10 | 2016 | 1300 | 0.200 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 198 | 0.200 |
Why?
|
| Occupational Diseases | 2 | 2015 | 48 | 0.200 |
Why?
|
| Smoking | 3 | 2015 | 505 | 0.180 |
Why?
|
| Clinical Competence | 2 | 2015 | 330 | 0.180 |
Why?
|
| Postoperative Complications | 2 | 2017 | 823 | 0.170 |
Why?
|
| Agricultural Workers' Diseases | 2 | 2011 | 36 | 0.170 |
Why?
|
| Sleep | 2 | 2019 | 84 | 0.160 |
Why?
|
| Ultrasonography, Interventional | 2 | 2012 | 55 | 0.160 |
Why?
|
| Conscious Sedation | 2 | 2017 | 24 | 0.160 |
Why?
|
| Socioeconomic Factors | 3 | 2016 | 388 | 0.160 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 757 | 0.150 |
Why?
|
| United States | 4 | 2016 | 4072 | 0.150 |
Why?
|
| Foreign Bodies | 2 | 2009 | 28 | 0.140 |
Why?
|
| Age Distribution | 3 | 2014 | 194 | 0.140 |
Why?
|
| Depression | 2 | 2012 | 420 | 0.140 |
Why?
|
| Preoperative Care | 1 | 2019 | 125 | 0.140 |
Why?
|
| Patient Care Team | 1 | 2019 | 124 | 0.140 |
Why?
|
| Age of Onset | 2 | 2015 | 90 | 0.140 |
Why?
|
| Bronchoalveolar Lavage | 2 | 2017 | 15 | 0.140 |
Why?
|
| Cross-Sectional Studies | 4 | 2014 | 1479 | 0.130 |
Why?
|
| Retrospective Studies | 4 | 2014 | 3626 | 0.130 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2017 | 6 | 0.130 |
Why?
|
| Housing | 2 | 2014 | 35 | 0.130 |
Why?
|
| Health Care Surveys | 2 | 2016 | 184 | 0.130 |
Why?
|
| Cough | 1 | 2017 | 19 | 0.130 |
Why?
|
| Airway Obstruction | 2 | 2015 | 29 | 0.130 |
Why?
|
| Midazolam | 1 | 2016 | 11 | 0.120 |
Why?
|
| Anesthetics, Intravenous | 1 | 2016 | 18 | 0.120 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2016 | 28 | 0.120 |
Why?
|
| Fentanyl | 1 | 2016 | 33 | 0.120 |
Why?
|
| Respiratory Distress Syndrome, Adult | 1 | 2016 | 50 | 0.120 |
Why?
|
| Prospective Studies | 4 | 2019 | 2316 | 0.120 |
Why?
|
| Treatment Outcome | 3 | 2013 | 3416 | 0.120 |
Why?
|
| Physical Therapy Modalities | 1 | 2016 | 82 | 0.120 |
Why?
|
| Respiration, Artificial | 1 | 2016 | 98 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 444 | 0.120 |
Why?
|
| Infant | 2 | 2015 | 1010 | 0.110 |
Why?
|
| Poultry | 1 | 2015 | 13 | 0.110 |
Why?
|
| Length of Stay | 1 | 2016 | 321 | 0.110 |
Why?
|
| Food-Processing Industry | 1 | 2015 | 21 | 0.110 |
Why?
|
| Risk Factors | 5 | 2014 | 3934 | 0.110 |
Why?
|
| Patient Care Planning | 1 | 2015 | 55 | 0.110 |
Why?
|
| Child, Preschool | 2 | 2015 | 1233 | 0.110 |
Why?
|
| Oximetry | 2 | 2016 | 32 | 0.100 |
Why?
|
| Health Status | 2 | 2016 | 355 | 0.100 |
Why?
|
| Air Pollution, Indoor | 1 | 2014 | 8 | 0.100 |
Why?
|
| Immunocompromised Host | 1 | 2014 | 53 | 0.100 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 245 | 0.100 |
Why?
|
| Infant, Newborn | 1 | 2015 | 666 | 0.100 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2013 | 2 | 0.100 |
Why?
|
| Granular Cell Tumor | 1 | 2013 | 2 | 0.100 |
Why?
|
| Bronchial Diseases | 1 | 2013 | 4 | 0.100 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2014 | 105 | 0.100 |
Why?
|
| Papilloma | 1 | 2013 | 8 | 0.100 |
Why?
|
| Hamartoma | 1 | 2013 | 9 | 0.100 |
Why?
|
| Mediastinal Diseases | 1 | 2012 | 5 | 0.100 |
Why?
|
| Leiomyoma | 1 | 2013 | 15 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2017 | 854 | 0.090 |
Why?
|
| Obesity | 2 | 2016 | 1111 | 0.090 |
Why?
|
| Biopsy, Needle | 1 | 2012 | 95 | 0.090 |
Why?
|
| Sex Factors | 1 | 2014 | 655 | 0.090 |
Why?
|
| Respiratory Aspiration | 2 | 2009 | 24 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 183 | 0.090 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 757 | 0.090 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 248 | 0.090 |
Why?
|
| Poultry Products | 1 | 2012 | 8 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2012 | 113 | 0.090 |
Why?
|
| Bronchi | 2 | 2009 | 33 | 0.090 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2012 | 7 | 0.090 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 556 | 0.090 |
Why?
|
| Child | 2 | 2015 | 2435 | 0.090 |
Why?
|
| Drug Combinations | 1 | 2012 | 101 | 0.090 |
Why?
|
| Smoking Cessation | 1 | 2014 | 211 | 0.090 |
Why?
|
| Homeless Persons | 1 | 2011 | 3 | 0.090 |
Why?
|
| Risk | 1 | 2012 | 305 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 292 | 0.080 |
Why?
|
| Incidence | 1 | 2014 | 1241 | 0.080 |
Why?
|
| Blood Pressure Monitors | 1 | 2010 | 4 | 0.080 |
Why?
|
| Family Characteristics | 1 | 2011 | 32 | 0.080 |
Why?
|
| Electronic Mail | 1 | 2010 | 20 | 0.080 |
Why?
|
| Physician's Role | 1 | 2010 | 41 | 0.080 |
Why?
|
| European Continental Ancestry Group | 1 | 2014 | 1076 | 0.080 |
Why?
|
| Focus Groups | 1 | 2010 | 123 | 0.080 |
Why?
|
| Data Collection | 1 | 2010 | 171 | 0.080 |
Why?
|
| Critical Illness | 1 | 2010 | 87 | 0.080 |
Why?
|
| Disease Progression | 1 | 2012 | 591 | 0.080 |
Why?
|
| Critical Care | 1 | 2010 | 108 | 0.080 |
Why?
|
| Prescriptions | 1 | 2009 | 15 | 0.070 |
Why?
|
| Blood Gas Analysis | 1 | 2009 | 16 | 0.070 |
Why?
|
| Pleural Effusion | 1 | 2009 | 15 | 0.070 |
Why?
|
| Trachea | 1 | 2009 | 53 | 0.070 |
Why?
|
| African Americans | 1 | 2014 | 1335 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2017 | 1840 | 0.060 |
Why?
|
| Respiratory Function Tests | 2 | 2015 | 93 | 0.050 |
Why?
|
| Health Surveys | 2 | 2013 | 175 | 0.040 |
Why?
|
| Lung | 2 | 2014 | 263 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2019 | 308 | 0.030 |
Why?
|
| Cholinergic Antagonists | 1 | 2017 | 10 | 0.030 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2017 | 11 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2017 | 37 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2017 | 43 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2017 | 81 | 0.030 |
Why?
|
| Demography | 1 | 2016 | 101 | 0.030 |
Why?
|
| Outpatients | 1 | 2016 | 57 | 0.030 |
Why?
|
| Neck | 1 | 2016 | 32 | 0.030 |
Why?
|
| Office Visits | 1 | 2016 | 72 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 252 | 0.030 |
Why?
|
| Hand Strength | 1 | 2016 | 98 | 0.030 |
Why?
|
| Resistance Training | 1 | 2016 | 58 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2016 | 95 | 0.030 |
Why?
|
| Mental Health | 1 | 2016 | 111 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2016 | 368 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2016 | 204 | 0.030 |
Why?
|
| Lymphatic Diseases | 1 | 2014 | 11 | 0.030 |
Why?
|
| Mediastinal Neoplasms | 1 | 2014 | 15 | 0.030 |
Why?
|
| Cockroaches | 1 | 2014 | 1 | 0.030 |
Why?
|
| Infectious Disease Medicine | 1 | 2014 | 2 | 0.030 |
Why?
|
| Rodentia | 1 | 2014 | 9 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 853 | 0.030 |
Why?
|
| Spirometry | 1 | 2014 | 25 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2013 | 11 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2014 | 69 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 131 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 161 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2014 | 194 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2016 | 863 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2014 | 90 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 128 | 0.020 |
Why?
|
| Animals | 2 | 2015 | 8199 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 168 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 287 | 0.020 |
Why?
|
| Accidents, Occupational | 1 | 2011 | 6 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 471 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 461 | 0.020 |
Why?
|
| Respiratory Sounds | 1 | 2011 | 8 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2011 | 141 | 0.020 |
Why?
|
| Community-Based Participatory Research | 1 | 2011 | 114 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 381 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2011 | 187 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2011 | 456 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 651 | 0.020 |
Why?
|
| Prognosis | 1 | 2013 | 1534 | 0.020 |
Why?
|
| Laboratories, Hospital | 1 | 2009 | 5 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 69 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 743 | 0.020 |
Why?
|
| Transducers | 1 | 2008 | 14 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2008 | 62 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2008 | 106 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 180 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 191 | 0.020 |
Why?
|